Subcutaneous melanocytoma mimicking a lipoma: a rare presentation of a rare neoplasm with histological, immunohistochemical, cytogenetic and molecular characterization
Nitin Marwaha
Department of Pathology, Saint Louis University School of Medicine, St. Louis, MO, USA
Search for more papers by this authorJacqueline R. Batanian
Department of Pathology, Saint Louis University School of Medicine, St. Louis, MO, USA
Search for more papers by this authorJeroen R. Coppens
Department of Neurosurgery, Saint Louis University School of Medicine, St. Louis, MO, USA
Search for more papers by this authorMatthew J. Pierson
Department of Neurosurgery, Saint Louis University School of Medicine, St. Louis, MO, USA
Search for more papers by this authorJennifer Richards-Yutz
Department of Genetics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
Search for more papers by this authorJessica Ebrahimzadeh
Department of Genetics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
Search for more papers by this authorArupa Ganguly
Department of Genetics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
Search for more papers by this authorCorresponding Author
Miguel A. Guzman
Department of Pathology, Saint Louis University School of Medicine, St. Louis, MO, USA
Miguel A. Guzman, MD,
Department of Pathology, Saint Louis University School of Medicine, St. Louis, MO, USA
Tel: 314-577-5337
Fax: 314-268-6407
e-mail: [email protected]
Search for more papers by this authorNitin Marwaha
Department of Pathology, Saint Louis University School of Medicine, St. Louis, MO, USA
Search for more papers by this authorJacqueline R. Batanian
Department of Pathology, Saint Louis University School of Medicine, St. Louis, MO, USA
Search for more papers by this authorJeroen R. Coppens
Department of Neurosurgery, Saint Louis University School of Medicine, St. Louis, MO, USA
Search for more papers by this authorMatthew J. Pierson
Department of Neurosurgery, Saint Louis University School of Medicine, St. Louis, MO, USA
Search for more papers by this authorJennifer Richards-Yutz
Department of Genetics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
Search for more papers by this authorJessica Ebrahimzadeh
Department of Genetics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
Search for more papers by this authorArupa Ganguly
Department of Genetics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
Search for more papers by this authorCorresponding Author
Miguel A. Guzman
Department of Pathology, Saint Louis University School of Medicine, St. Louis, MO, USA
Miguel A. Guzman, MD,
Department of Pathology, Saint Louis University School of Medicine, St. Louis, MO, USA
Tel: 314-577-5337
Fax: 314-268-6407
e-mail: [email protected]
Search for more papers by this authorAbstract
Melanocytoma are the melanocytic tumors originating from leptomeningeal melanocytes. Melanocytomas are commonly seen in the central nervous system (CNS) and are often associated with neurocutaneous melanosis (NCM). However, simultaneous presentation of intra-axial and extracranial melanocytoma is a very rare event. Here, we report a unique case of 21-year-old male with intermediate-grade subcutaneous (SC) melanocytoma, mimicking lipoma, occurred synchronously with an intracranial melanocytoma, not associated with NCM. A 21-year-old Caucasian male presented to the emergency department (ED) with severe vertigo and vomiting. A magnetic resonance imaging (MRI) of the brain was performed at the ED, which revealed an SC mass in the right occipital scalp and a right cerebellopontine angle (CPA) mass. Excision of the SC mass revealed a well-circumscribed highly pigmented melanocytic tumor. The SC mass tumor cells were positive for melanocytic lineage markers. The histopathological features were between benign melanocytomas and malignant melanomas. The Ki67 and PHH3 IHCs confirm the intermediate grade of the tumors. An array-CGH (comparative genome hybridization) and next-generation sequencing analysis of the tumor DNA extracted from the formalin-fixed paraffin-embedded tissue reveals chromosome 6p gain and p.Q209P mutation in the GNAQ gene, respectively, consistent with the diagnosis of intermediate-grade melanocytoma.
References
- 1Brat DJ, Giannini C, Scheithauer BW, Burger PC. Primary melanocytic neoplasms of the central nervous systems. Am J Surg Pathol 1999; 23: 745.
- 2Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. World Health Organization histological classification of tumours of the central nervous system. Lyon: International Agency for Research on Cancer, 2016.
- 3Bastian BC. The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia. Annu Rev Pathol 2014; 9: 239.
- 4Jellinger K, Bock F, Brenner H. Meningeal melanocytoma. Report of a case and review of the literature. Acta Neurochir 1988; 94: 78.
- 5Lin B, Yang H, Qu L, Li Y, Yu J. Primary meningeal melanocytoma of the anterior cranial fossa: a case report and review of the literature. World J Surg Oncol 2012; 10: 135.
- 6Dorwal P, Mohapatra I, Gautam D, Gupta A. Intramedullary melanocytoma of thoracic spine: a rare case report. Asian J Neurosurg 2014; 9: 36.
- 7Assis ZA, Dadlani R, Kumaran SP, Ghosal N. Supratentorial parenchymal CNS melanocytoma – report of a rare case. Neurol India 2014; 62: 701.
- 8Costa S, Byrne M, Pissaloux D, et al. Melanomas associated with blue nevi or mimicking cellular blue nevi: clinical, pathologic, and molecular study of 11 cases displaying a high frequency of GNA11 mutations, BAP1 expression loss, and a predilection for the scalp. Am J Surg Pathol 2016; 40: 368.
- 9Harbour JW, Onken MD, Roberson ED, et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 2010; 330: 1410. DOI: 10.1126/science.1194472.
- 10Liubinas SV, Maartens N, Drummond KJ. Primary melanocytic neoplasms of the central nervous system. J Clin Neurosci 2010; 17: 1227.
- 11Neves SR, Ram PT, Iyengar R. G protein pathways. Science 2002; 296: 1636.
- 12Markby DW, Onrust R, Bourne HR. Separate GTP binding and GTPase acti-vating domains of a G alpha subunit. Science 1993; 262: 1895.
- 13Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 1989; 340: 692.
- 14Kusters-Vandevelde HV, van Engen-van Grunsven IA, Coupland SE, et al. Mutations in g protein encoding genes and chromosomal alterations in primary leptomeningeal melanocytic neoplasms. Pathol Oncol Res 2015; 21: 439.
- 15Kusters-Vandevelde HV, Klaasen A, Kusters B, et al. Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system. Acta Neuropathol 2009; 119: 317.
- 16Murali R, Wiesner T, Rosenblum MK, Bastian BC. GNAQ and GNA11 mutations in melanocytomas of the central nervous system. Acta Neuropathol 2012; 123: 457.
- 17Gessi M, Hammes J, Lauriola L, et al. GNA11 and N-RAS mutations: alternatives for MAPK pathway activating GNAQ mutations in primary melanocytic tumours of the central nervous system. Neuropathol Appl Neurobiol 2012; 39: 417.
- 18Fuld AD, Speck ME, Harris BT, et al. Primary melanoma of the spinal cord: a case report, molecular footprint, and review of the literature. J Clin Oncol 2011; 29: e499. DOI: 10.1200/jco.2010.34.0695.
- 19Wang F, Li X, Chen L, Pu X. Malignant transformation of spinal meningeal melanocytoma. Case report and review of the literature. J Neurosurg Spine 2007; 6: 451.
- 20Yang C, Fang J, Li G, Yang J, Xu Y. Primary scattered multifocal melanocytomas in spinal canal mimicking neurofibromatosis. Spine J 2016; 16(8): e553.
- 21Wang YB, Wang WJ, Zhao HT, Li W, Peng T, Zhang XF. Multiple melanocytoma of the thoracic spine: a case report and literature review. Spine J 2015; 16(1): e59.
- 22Foit NA, Neidert MC, Woernle CM, Rushing EJ, Krayenbuhl N. Bifocal extra- and intradural melanocytoma of the spine: case report and literature review. Eur Spine J 2013; 22(Suppl 3): S521. DOI: 10.1007/s00586-013-2773-x.
- 23Huang X, Pan X, Huang H, Zhan R. Multiple spinal cord melanoma: case report with emphasis on the difficult preoperative diagnosis. Turk Neurosurg 2013; 23: 534.
- 24Kurokawa R, Kim P, Kawamoto T, et al. Intramedullary and retroperitoneal melanocytic tumor associated with congenital blue nevus and nevus flammeus: an uncommon combination of neurocutaneous melanosis and phacomatosis pigmentovascularis – case report. Neurol Med Chir 2013; 53: 730.
- 25Reddy R, Krishna V, Sahu BP, Uppin M, Sundaram C. Multifocal spinal meningeal melanocytoma: an illustrated case review. Turk Neurosurg 2012; 22: 791. DOI: 10.5137/1019-5149.jtn.4322-11.1.
- 26Merciadri P, Secci F, Sbaffi PF, Zona G. Multifocal meningeal melanocytoma of the conus medullaris. Acta Neurochir 2011; 153: 2283. DOI: 10.1007/s00701-011-1143-x.
- 27Franken SP, Setz-Pels W, Smink-Bol M, et al. Unusual case of bifocal leptomeningeal melanocytoma in the posterior fossa with seeding in the spinal canal. Br J Radiol 2009; 82: e182.
- 28Ali Y, Rahme R, Moussa R, Abadjian G, Menassa-Moussa L, Samaha E. Multifocal meningeal melanocytoma: a new pathological entity or the result of leptomeningeal seeding? J Neurosurg 2009; 111: 488.
- 29O'Brien TF, Moran M, Miller JH, Hensley SD. Meningeal melanocytoma. An uncommon diagnostic pitfall in surgical neuropathology. Arch Pathol Lab Med 1995; 119: 542.
- 30Le Douarin NMKC. The neural crest. Cambridge: Cambridge University Press, 1999.
10.1017/CBO9780511897948 Google Scholar
- 31Balmaceda CM, Fetell MR, O'Brien JL, Housepian EH. Nevus of Ota and leptomeningeal melanocytic lesions. Neurology 1993; 43: 381.
- 32Piercecchi-Marti MD, Mohamed H, Liprandi A, Gambarelli D, Grisoli F, Pellissier JF. Intracranial meningeal melanocytoma associated with ipsilateral nevus of Ota. J Neurosurg 2002; 96: 619.
- 33Kawara S, Takata M, Hirone T, Tomita K, Hamaoka H. A new variety of neurocutaneous melanosis: benign leptomeningeal melanocytoma associated with extensive Mongolian spot on the back. Nihon Hifuka Gakkai Zasshi 1989; 99: 561.
- 34Domingues MJ, Larue L, Bonaventure J. Migration of melanocytic lineage-derived cells. Med Sci 2013; 29: 287.
- 35Van Raamsdonk CD, Griewank KG, Crosby MB, et al. Mutations in GNA11 in uveal melanoma. N Engl J Med 2010; 363: 2191.
- 36Brat DJ. Melanocytic neoplasms of the central nervous system. In A Perry, DJ Brat, eds. Practical surgical neuropathology. Philadelphia: Churchill Livingstone, 2010; 353.
10.1016/B978-0-443-06982-6.00016-X Google Scholar
- 37Van Raamsdonk CD, Bezrookove V, Green G, et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 2009; 457: 599. DOI: 10.1038/nature07586.
- 38Khodadoust MS, Verhaegen M, Kappes F, et al. Melanoma proliferation and chemoresistance controlled by the DEK oncogene. Cancer Res 2009; 69: 6405.
- 39Horsman DE, White VA. Cytogenetic analysis of uveal melanoma. Consistent occurrence of monosomy 3 and trisomy 8q. Cancer 1993; 71: 811.
10.1002/1097-0142(19930201)71:3<811::AID-CNCR2820710325>3.0.CO;2-F CAS PubMed Web of Science® Google Scholar
- 40Onken MD, Worley LA, Ehlers JP, Harbour JW. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 2004; 64: 7205.
- 41Torres-Mora J, Dry S, Li X, Binder S, Amin M, Folpe AL. Malignant melanotic schwannian tumor: a clinicopathologic, immunohistochemical, and gene expression profiling study of 40 cases, with a proposal for the reclassification of “melanotic schwannoma”. Am J Surg Pathol 2014; 38: 94.
- 42Koelsche C, Hovestadt V, Jones DT, et al. Melanotic tumors of the nervous system are characterized by distinct mutational, chromosomal and epigenomic profiles. Brain Pathol 2015; 25: 202.
- 43Bastian BC, LeBoit PE, Hamm H, et al. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res 1998; 58: 2170.
- 44Kusters-Vandevelde HV, van Engen-van Grunsven IA, Kusters B, et al. Improved discrimination of melanotic schwannoma from melanocytic lesions by combined morphological and GNAQ mutational analysis. Acta Neuropathol 2010; 120: 755.
- 45Strom RG, Shvartsbeyn M, Rosenblum MK, et al. Melanocytic tumor with GNA11 p.Q209L mutation mimicking a foramen magnum meningioma. Clin Neurol Neurosurg 2012; 114: 1197. DOI: 10.1016/j.clineuro.2012.02.030.
- 46Yoo JH, Shi DS, Grossmann AH, et al. ARF6 is an actionable node that orchestrates oncogenic GNAQ signaling in uveal melanoma. Cancer Cell 2016; 29: 889. DOI: 10.1016/j.ccell.2016.04.015.
- 47Lyubasyuk V, Ouyang H, Yu FX, Guan KL, Zhang K. YAP inhibition blocks uveal melanogenesis driven by GNAQ or GNA11 mutations. Mol Cell Oncol 2015; 2: e970957. DOI: 10.4161/23723548.2014.970957.